October 19, 2020 • 2 mins read CureTalks Launches New Talk Series on Contribution of Small Biotech Companies Towards Drug Development of Orphan Diseases CureTalks launches its new series featuring biotech companies at the cutting edge of innovation and breakthrough research with the purpose of bringing their contributions…
June 1, 2020 • 4 mins read Hydroxychloroquine, when Politics and Science Intersect Hydroxychloroquine, When Politics And Science Intersect
November 14, 2017 • 6 mins read CAR-T Cell Therapy Clinical Trials – Promising Advancement in Medicine Two radically new gene based immunotherapies were approved by the FDA this year – Kymriah followed by Yescarta – in August and October, respectively.…
March 28, 2017 • 3 mins read Clinical Trial Failures – Losses of 2016 Drug development costs are increasing and the time it takes to bring a drug to market is becoming longer. Also of consideration is the…
March 1, 2017 • 9 mins read Key FDA Approved Drugs in 2016 While President Trump believes that ‘slow and burdensome’ FDA drug approval process is ‘keeping too many new drugs from reaching the market’, former FDA…